Linden Advisors’s Tevogen Inc. Common Stock TVGN Stock Holding History

Linden Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,669	Closed	-$862K	–	482
2022 Q4	$862K	Hold	1,669	–	–	0.01%	316
2022 Q3	$847K	Hold	1,669	–	–	0.01%	381
2022 Q2	$835K	Sell	1,669 -24,331	-94%	-$12.2M	0.01%	416
2022 Q1	$13M	Buy	+26,000	New	+$12.9M	0.08%	160

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Linden Advisors's TVGN Position: Q1 2023 in Review

Linden Advisors sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 1,669 shares — an estimated $862K sold.

Linden Advisors first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $13M in Q1 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Linden Advisors reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Linden Advisors sold 1,669 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $862K.
Linden Advisors first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Linden Advisors's Tevogen Inc. Common Stock position peaked at $13M in Q1 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Linden Advisors's 13F filing for Q1 2023, filed 15 May 2023.